Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. - Wikidata - wikimedia - TriplyDB

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.

http://www.wikidata.org/entity/Q34191508

about

The roles of viruses in brain tumor initiation and oncomodulation Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas Specific visualization of glioma cells in living low-grade tumor tissue The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease PTEN loss accelerates KrasG12D-induced pancreatic cancer development Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome Biologically targeted therapeutics in pediatric brain tumors.Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma.Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.Nimotuzumab in pediatric glioma.Diffuse intrinsic pontine glioma-current status and future strategies.Treatment of high-grade glioma in children and adolescents.Paediatric and adult malignant glioma: close relatives or distant cousins?Pediatric neuro-oncology: current status and future directions.The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma.Peptide arrays for development of PDGFRβ Affine molecules.Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition.Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors.A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG).Overexpression of mTOR and p(240-244)S6 in IDH1 Wild-Type Human Glioblastomas Is Predictive of Low Survival.The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities.Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades.

P2860

Q24632829-F3A07370-E968-4970-82D4-6D5D76B7CC13 Q24649190-37000178-CFF5-4546-B65E-F84BBA1E90ED Q27324581-6B154504-08E9-4380-A679-DAB8A0BE2A3D Q28070264-E4FA56A3-BE73-4741-B282-82A4DF32E49C Q30412209-E9D358D0-791C-4E76-9155-E3A3F9B806C5 Q30474678-BD75E1F3-885A-41AA-977C-0EDF935E4503 Q33438006-47DA877B-6AF8-4BA1-83D8-E74632567D27 Q33764664-4307ECF5-51A3-4048-B606-FD8CE67C8906 Q33863314-25EBC6D1-84F2-4BC0-B664-D3536488FD2E Q33990951-E52157E6-D5A8-4756-8840-2AE12EFDD5F9 Q34134396-ACAFD631-3290-42C6-88E1-22F36DC6319E Q34196216-A45B7FB2-6173-4CE3-B709-03186F1AF73F Q34286305-FF6F73FE-C2DA-4B7D-8565-0D19D1C7ADF7 Q34393758-C2BBAD2B-76A0-4E3B-A075-F1457C612B31 Q34480582-3EADD383-C430-4FF4-B534-651CC51D599C Q34722504-58238F45-77F4-4770-AE9F-5A16C4916AB6 Q35738941-0B6EC166-A6FE-42E2-8934-DF37D9FFA2E4 Q35945582-4E7A3F52-0F1B-408F-BDBC-F98ADBC22E46 Q36020891-17B4C548-C5A5-45AA-A02C-190524CC585C Q36179171-C18D68D3-46F2-4AF5-BD92-97E1C5C71794 Q36844744-1DF24291-BBD6-433E-9929-949C39B6F745 Q37318631-AF0EFB84-4832-4519-85A7-B42ABE09DD5F Q37345320-E96C90EA-6BDE-4668-AF0D-386D82CA7A1C Q37564201-993D7995-2707-465E-8123-E4B3F2630B5C Q37630569-FAC5514F-EB05-4D15-9192-061359BC2C16 Q37870759-6B812CCE-952F-497A-958B-34558BF0562F Q37904503-430BBE8C-F0A1-4890-B625-107E84BB145B Q38013990-064F3B81-49A3-488E-84DD-CD1D8F2FAC51 Q38035070-BEBF2638-EF98-4C4C-B6D5-D008451161FB Q38832520-5443265C-0108-46BE-BEC8-482910E1807F Q38904545-B4830C3B-E924-4265-88A3-FBBBB8A1D6D8 Q39199620-47D7E528-4AEE-41B5-ACBD-3246B3A9E032 Q39208269-8BA20BD1-F91A-4833-AEAF-57662EBFE0F8 Q39425287-DA3DBB80-2C76-480F-B668-095C6739FF62 Q42654003-390BD42A-8C11-448B-BDCC-6DA50D4AB456 Q44819993-D3BE044B-51FA-4B44-8EF1-3C1D4348AF28 Q46088442-4E8D6799-1A66-42B9-9615-1296519C9DF0 Q47867724-421C496B-D413-4AC1-94CD-94C0294686C6 Q48000346-AE1EA0A6-C72A-4FC7-965E-DD7CD21B98D4 Q48450513-D24C6597-CED7-49B7-9C01-8B5CF7A30F04

P2860

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.

http://www.wikidata.org/entity/Q34191508

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Protein expression of platelet ...... survival in childhood gliomas.

@ast

Protein expression of platelet ...... survival in childhood gliomas.

@en

Protein expression of platelet ...... survival in childhood gliomas.

@nl

type

label

Protein expression of platelet ...... survival in childhood gliomas.

@ast

Protein expression of platelet ...... survival in childhood gliomas.

@en

Protein expression of platelet ...... survival in childhood gliomas.

@nl

prefLabel

Protein expression of platelet ...... survival in childhood gliomas.

@ast

Protein expression of platelet ...... survival in childhood gliomas.

@en

Protein expression of platelet ...... survival in childhood gliomas.

@nl

P1433

Q34191508-7E398FCC-B60F-4B0F-9E9D-840E3AE6B3BD

P1476

Q34191508-F11BEDA5-ACBF-4B1A-8871-29A6FBE3F09C

P2093

Q34191508-3C6CB780-0466-43E5-992E-00343B0605B7

Q34191508-597FF63B-45EC-44E3-8129-3726788405A4

Q34191508-61F9DF55-AB32-47A4-B5B0-A03C9A25F84C

Q34191508-64F6757F-A898-4331-B241-7D068BD9B7F1

Q34191508-6C9C2D5A-DA4A-494E-B0D7-137E70F2A779

Q34191508-71CB6E8B-1079-4A90-AC84-136276EBD8C4

Q34191508-9BF165A6-95AE-4C94-A789-15F87AC83CFD

P2860

Q34191508-02A26690-ADF3-45BA-81BF-32169A803655

Q34191508-04B729B8-0540-4648-A1FD-B3C9CCC5BA79

Q34191508-0744210D-CAB0-4424-8AAE-13DABE3CA373

Q34191508-0C26E379-503D-4F76-A163-85DA1FB3AF87

Q34191508-228FEAE0-5D73-48F9-AAFB-E8980FF013A9

Q34191508-33032854-E7F4-4DBE-84C5-7EED00C26A71

Q34191508-331FBB42-F929-458F-885C-FC0860023F40

Q34191508-3BC5B073-17A9-4EFE-953E-6E977DA7024E

Q34191508-4411C80C-E185-4961-B429-9A97B4499EF5

Q34191508-556B2F9E-88E8-4B1A-BA11-B318EE413FC5

P304

Q34191508-C0818C81-6EC5-4B3D-8881-A55A8EF72868

P31

Q34191508-0AA2D716-99B4-4ED2-85C5-FA05AEF10AF1

P356

Q34191508-5A27BBF6-D08D-42CD-B823-E869670279A5

P407

Q34191508-79D986BD-CD71-4B21-A3DE-5906F02B07A6

P433

Q34191508-66288A33-EFFF-4496-8FE2-5E69B848D8DF

P478

Q34191508-44DE2C86-6E6F-4001-93B9-8C2FB357BBA7

P577

Q34191508-695018B8-DD41-423B-86DE-6D0603B1E415

P698

Q34191508-6D27F9E0-E21A-49ED-876D-C6EAAF9A28D4

P932

Q34191508-3009419C-07B4-479C-86A2-FBB67AA9C0E7

P356

1078-0432.CCR-07-1616

P1433

Clinical Cancer Research

P1476

Protein expression of platelet ...... survival in childhood gliomas.

@en

P2093

Alessandra Jales

http://www.w3.org/2001/XMLSchema#string

Elisabeth J Rushing

http://www.w3.org/2001/XMLSchema#string

Halldora K Thorarinsdottir

http://www.w3.org/2001/XMLSchema#string

Mariarita Santi

http://www.w3.org/2001/XMLSchema#string

Robert Cornelison

http://www.w3.org/2001/XMLSchema#string

Robert McCarter

http://www.w3.org/2001/XMLSchema#string

Tobey J MacDonald

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.

Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

Primary and secondary glioblastomas: from concept to clinical diagnosis

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.

Pediatric glial tumors.

Targeted molecular therapy of GBM.

Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.

Prospective clinical trials of intracranial low-grade glioma in adults and children.

Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.

P304

3386-3394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-1616

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18519768

http://www.w3.org/2001/XMLSchema#string

P932

2953416

http://www.w3.org/2001/XMLSchema#string